Editorial: Endocrine organoids for modeling, drug development, and treatment of cancer and other diseases

Vijaya Kumar Pidugu; Anil Mathew Tharappel; Sonam Kumari; Kumar Sanjiv

doi:10.3389/fendo.2023.1292619

Editorial: Endocrine organoids for modeling, drug development, and treatment of cancer and other diseases

Front Endocrinol (Lausanne). 2023 Sep 25:14:1292619. doi: 10.3389/fendo.2023.1292619. eCollection 2023.

Authors

Vijaya Kumar Pidugu¹, Anil Mathew Tharappel², Sonam Kumari³, Kumar Sanjiv⁴

Affiliations

¹ Laboratory of Cancer Biology and Genetics, Center for Cancer Research, National Cancer Institute, Bethesda, MD, United States.
² Department of Pharmacology and Toxicology, R. Ken Coit College of Pharmacy, The University of Arizona, Tucson, AZ, United States.
³ National Institutes of Health, Bethesda, MD, United States.
⁴ Scilifelab, Department of Oncology, Pathology, Karolinska Institute, Solna, Sweden.

No abstract available

Keywords: ECM matrix scaffold; colorectal cancer; endocrine organoid models; endometrium; papillary thyroid cancer; patient-derived organoids; pituitary gland; stem cells.

Publication types

Editorial

MeSH terms

Drug Development
Humans
Neoplasms* / drug therapy
Organoids